Literature DB >> 20842379

Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries.

Javier Diez-Domingo1, Jose-Maria Baldo, Marian Patrzalek, Petr Pazdiora, Johannes Forster, Luigi Cantarutti, Jean-Yves Pirçon, Montse Soriano-Gabarró, Nadia Meyer.   

Abstract

This observational, prospective study was undertaken to estimate the burden of rotavirus (RV) gastroenteritis (GE) leading to general practitioner (GP)/family paediatrician (FP) visits among children aged <5 years in Czech Republic, Germany, Italy, Poland, Spain and the UK. Children aged <5 years presenting with acute GE provided stool samples for rapid RV testing. RV+ samples were confirmed and typed by RT-PCR. Demographic and clinical data were collected for all RVGE episodes. Transmission patterns among other household children aged <5 years were also assessed. From November 2005 to May 2007, excluding data from the UK, 497/3,813 (13.0%) children aged <5 years presenting with acute GE to GP/FP and tested were RV+ by PCR. Most RVGE cases (69.1%) occurred in children aged <2 years, occurred between December and May (93.1%) and were moderate or severe by Vesikari score (92.9%). RV strain distribution varied between countries: G9P[8] was the most common type in Poland (54/76) and Spain (172/196), G1P[8] was predominant in the Czech Republic (56/64) and Italy (46/107), and G4P[8] and G1P[8] both prevailed in Germany (17/54 and 13/54, respectively). A total of 24/122 (19.7%) children aged <5 years resident in the same household as a PCR+ study participant also developed RVGE. Conclusion. This multinational epidemiological study in Europe shows that RV is easily transmitted among household children, with RVGE burden highest among children aged <2 years accessing primary healthcare for acute GE.

Entities:  

Mesh:

Year:  2010        PMID: 20842379     DOI: 10.1007/s00431-010-1289-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  31 in total

1.  Rotavirus genotyping: keeping up with an evolving population of human rotaviruses.

Authors:  Miren Iturriza-Gómara; Gagandeep Kang; Jim Gray
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

2.  Rotavirus vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-08-10

3.  Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-06-05

4.  Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine.

Authors:  Hwa-Gan H Chang; Perry F Smith; Bold Tserenpuntsag; Katherine Markey; Umesh Parashar; Dale L Morse
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

Review 5.  Transmission of rotavirus and other enteric pathogens in the home.

Authors:  P H Dennehy
Journal:  Pediatr Infect Dis J       Date:  2000-10       Impact factor: 2.129

6.  Climatic factors associated with hospitalizations for rotavirus diarrhoea in children under 5 years of age.

Authors:  R M D'Souza; G Hall; N G Becker
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

7.  Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland.

Authors:  Stephen B Lambert; Cassandra E Faux; Lisa Hall; Frances A Birrell; Karen V Peterson; Christine E Selvey; Theo P Sloots; Michael D Nissen; Keith Grimwood
Journal:  Med J Aust       Date:  2009-08-03       Impact factor: 7.738

8.  G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data.

Authors:  Jon R Gentsch; Jennifer J Hull; Elizabeth N Teel; Tara K Kerin; Molly M Freeman; Mathew D Esona; Dixie D Griffin; Brittany P Bielfelt-Krall; Krisztian Banyai; Baoming Jiang; Margaret M Cortese; Roger I Glass; Umesh D Parashar
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

9.  Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers.

Authors:  L K Pickering; A V Bartlett; R R Reves; A Morrow
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

10.  Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.

Authors:  T Ruuska; T Vesikari
Journal:  Scand J Infect Dis       Date:  1990
View more
  15 in total

Review 1.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

2.  Molecular Epidemiology of Rotavirus Strains in Under Five Children.

Authors:  Yunus Bulut; Gülgün Yenişehirli; Rıza Durmaz
Journal:  Indian J Pediatr       Date:  2017-11-29       Impact factor: 1.967

3.  Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.

Authors:  Javier Diez-Domingo; Nuria Lara Suriñach; Natalia Malé Alcalde; Lourdes Betegón; Nathalie Largeron; Mélanie Trichard
Journal:  BMC Public Health       Date:  2010-08-10       Impact factor: 3.295

4.  Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.

Authors:  Ioana Alina Anca; Florentina Ligia Furtunescu; Doina Pleşca; Adrian Streinu-Cercel; Sorin Rugină; Katsiaryna Holl
Journal:  Germs       Date:  2014-06-02

5.  Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study.

Authors:  Tessa Braeckman; Koen Van Herck; Nadia Meyer; Jean-Yves Pirçon; Montse Soriano-Gabarró; Elisabeth Heylen; Mark Zeller; Myriam Azou; Heidi Capiau; Jan De Koster; Anne-Sophie Maernoudt; Marc Raes; Lutgard Verdonck; Marc Verghote; Anne Vergison; Jelle Matthijnssens; Marc Van Ranst; Pierre Van Damme
Journal:  BMJ       Date:  2012-08-08

6.  The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices.

Authors:  Javier Diez Domingo; Marian Patrzalek; Luigi Cantarutti; Benoit Arnould; Juliette Meunier; Montse Soriano-Gabarro; Nadia Meyer; Jean-Yves Pirçon; Katsiaryna Holl
Journal:  BMC Pediatr       Date:  2012-05-31       Impact factor: 2.125

7.  Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.

Authors:  Greg L Plosker
Journal:  Drugs R D       Date:  2012-12-01

Review 8.  Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.

Authors:  Isla Ogilvie; Hanane Khoury; Mireille M Goetghebeur; Antoine C El Khoury; Carlo Giaquinto
Journal:  BMC Infect Dis       Date:  2012-03-19       Impact factor: 3.090

Review 9.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-05       Impact factor: 4.558

Review 10.  Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.